Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center

Highlights • HBV coinfection could affect late immunological and virological responses to ART. • HBV coinfection could increase the risk of hepatotoxicity during ART. • Mortality due to liver disease was high among HIV/HBV co-infected individuals.

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 28; no. C; pp. 29 - 34
Main Authors Yang, Rongrong, Gui, Xien, Xiong, Yong, Gao, Shi-cheng, Yan, Yajun
Format Journal Article
LanguageEnglish
Published Canada Elsevier 01.11.2014
Subjects
Acquired immunodeficiency syndrome
Adult
Anti-HIV Agents - adverse effects
Anti-HIV Agents - therapeutic use
CD4 Lymphocyte Count
Coinfection - drug therapy
Coinfection - mortality
End-stage liver diseases
Female
Hepatitis B - complications
Hepatitis B virus
Hepatotoxicity
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - mortality
Human immunodeficiency virus
Humans
Infectious Disease
Liver - drug effects
Male
Middle Aged
Pulmonary/Respiratory
Treatment Outcome
Young Adult
End-stage liver diseases
Hepatitis B virus
Human immunodeficiency virus
Hepatotoxicity
Acquired immunodeficiency syndrome
Online AccessGet full text

Cover

More Information
Summary:Highlights • HBV coinfection could affect late immunological and virological responses to ART. • HBV coinfection could increase the risk of hepatotoxicity during ART. • Mortality due to liver disease was high among HIV/HBV co-infected individuals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2014.07.018